| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/08/2023 | 41.01% | Benchmark | → $12 | Reiterates | Buy → Buy |
| 03/26/2021 | 41.01% | Benchmark | → $12 | Initiates Coverage On | → Buy |
What is the target price for Ultralife (ULBI)?
The latest price target for Ultralife (NASDAQ: ULBI) was reported by Benchmark on August 8, 2023. The analyst firm set a price target for $12.00 expecting ULBI to rise to within 12 months (a possible 41.01% upside). 1 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Ultralife (ULBI)?
The latest analyst rating for Ultralife (NASDAQ: ULBI) was provided by Benchmark, and Ultralife reiterated their buy rating.
When is the next analyst rating going to be posted or updated for Ultralife (ULBI)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Ultralife, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Ultralife was filed on August 8, 2023 so you should expect the next rating to be made available sometime around August 8, 2024.
Is the Analyst Rating Ultralife (ULBI) correct?
While ratings are subjective and will change, the latest Ultralife (ULBI) rating was a reiterated with a price target of $0.00 to $12.00. The current price Ultralife (ULBI) is trading at is $8.51, which is within the analyst's predicted range.